JP / EN

ExoEarth Global Longevity Ecosystem

ExoEarth is building a Japan-origin longevity platform that integrates exosome science, academic and clinical collaboration, biological data, and AI-driven analysis.
By connecting science, research, clinical implementation, and data intelligence, our ecosystem continues to evolve toward a more personalized and sustainable longevity future.


Message from the CEO

We have continued to ask what the human state truly is, guided by the idea of making the conscious unconscious and the unconscious conscious.
Human health and performance are determined before they become consciously perceived—in the unconscious biological activities of the body.
Inflammation, metabolism, immunity, neural function, and autonomic regulation.

These elements fluctuate every day and define the state that eventually appears as an observable result.
Conventional medicine and healthcare have been structured to intervene in “results” that rise into consciousness.
However, the essence lies in handling the changes that occur before those results appear.

ExoEarth targets this unconscious biological domain and designs a circular structure that continuously observes, intervenes, records, analyzes, and reflects the findings into the next stage of optimization.

This structure consists of EXO-FOOD, EXOCURE, EXOCURE AI, and the Platform, and functions as an integrated optimization foundation in which biological intervention and data analysis are unified.
Since 2019, we have operated this system continuously for more than six years and accumulated real-world data from more than 5,000 individuals.
This long-term real-world data is a learning foundation for individual optimization and is an important asset that can only be built through time.

From consciousness to the unconscious.
And from the unconscious back to consciousness.

By implementing this cycle as a structure, we aim to realize a society that treats health not as a “result,” but as a “process.”


Company Profile

Company NameExoEarth Corporation
EstablishedNovember 4, 2014
Location17F, World Trade Center Building South Tower,
2-4-1 Hamamatsucho, Minato-ku, Tokyo 105-5117, Japan 
DirectorTakashi Nishihira, President and CEO
Capital200 million yen, including capital reserve, as of March 2026
Business Activities
  • 1. Research and development related to diseases caused by telomere shortening and their solutions
  • 2. Research and planning development for the industrialization of biotechnology
  • 3. Research on anti-aging treatment products and sales of related products
  • 4. Wholesale, retail, import, and sales of cosmetics
  • 5. Product planning and development of cosmetics
  • 6. Manufacturing, sales, export, import, and distribution of health foods
  • 7. Consulting services related to the above items
  • 8. Any and all businesses incidental to the above items
Main BanksSumitomo Mitsui Banking Corporation, Ginza Branch / Mizuho Bank, Shimbashi Branch
Affiliated Organizations
  • Non-Profit Organization Wearable Environmental Information Network Promotion Organization 
  • Japan Sports Vision Association 
    Japan Sports Vision Medical Science Research Group
Partner Clinics
  • ZOI Clinic Tsukishima
    Clinical Collaboration / Physician-led Wellness Support

 Access